PROCAP FINANCIAL INC (BRR) Fundamental Analysis & Valuation

NASDAQ:BRR • US74277P1057

Current stock price

2.11 USD
+0.06 (+2.93%)
At close:
2.1342 USD
+0.02 (+1.15%)
After Hours:

This BRR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BRR Profitability Analysis

1.1 Basic Checks

  • BRR had negative earnings in the past year.
  • BRR had a negative operating cash flow in the past year.
BRR Yearly Net Income VS EBIT VS OCF VS FCFBRR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2024 2025 -5M -10M -15M -20M -25M

1.2 Ratios

  • With a Return On Assets value of -4.54%, BRR is not doing good in the industry: 79.58% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -6.90%, BRR is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA -4.54%
ROE -6.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRR Yearly ROA, ROE, ROICBRR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2024 2025 -500 -1K -1.5K

1.3 Margins

  • BRR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRR Yearly Profit, Operating, Gross MarginsBRR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2024 2025 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BRR Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BRR has been increased compared to 1 year ago.
  • BRR has a better debt/assets ratio than last year.
BRR Yearly Shares OutstandingBRR Yearly Shares OutstandingYearly Shares Outstanding 2024 2025 20M 40M 60M 80M
BRR Yearly Total Debt VS Total AssetsBRR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2024 2025 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 0.73, we must say that BRR is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of BRR (0.73) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.52 indicates that BRR is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.52, BRR is in the better half of the industry, outperforming 66.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 0.73
ROIC/WACCN/A
WACCN/A
BRR Yearly LT Debt VS Equity VS FCFBRR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • BRR has a Current Ratio of 87.21. This indicates that BRR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 87.21, BRR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • BRR has a Quick Ratio of 87.21. This indicates that BRR is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 87.21, BRR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 87.21
Quick Ratio 87.21
BRR Yearly Current Assets VS Current LiabilitesBRR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. BRR Growth Analysis

3.1 Past

  • The earnings per share for BRR have decreased strongly by -49050.00% in the last year.
EPS 1Y (TTM)-49050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRR Yearly Revenue VS EstimatesBRR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 20K 40K 60K 80K

More info and screens

Find the best growth stocksShow best growing peers

0

4. BRR Valuation Analysis

4.1 Price/Earnings Ratio

  • BRR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRR Price Earnings VS Forward Price EarningsBRR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRR Per share dataBRR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BRR Dividend Analysis

5.1 Amount

  • No dividends for BRR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BRR Fundamentals: All Metrics, Ratios and Statistics

PROCAP FINANCIAL INC

NASDAQ:BRR (3/31/2026, 4:55:47 PM)

After market: 2.1342 +0.02 (+1.15%)

2.11

+0.06 (+2.93%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-13
Earnings (Next)N/A
Inst Owners42.69%
Inst Owner ChangeN/A
Ins Owners1.84%
Ins Owner Change13.14%
Market Cap175.70M
Revenue(TTM)85.00K
Net Income(TTM)-28.98M
AnalystsN/A
Price TargetN/A
Short Float %1.78%
Short Ratio1.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2067.06
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.42
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS5.05
TBVpS5.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.54%
ROE -6.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 260.31%
Cap/Sales 99.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 87.21
Quick Ratio 87.21
Altman-Z 0.73
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33888.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

PROCAP FINANCIAL INC / BRR Fundamental Analysis FAQ

What is the fundamental rating for BRR stock?

ChartMill assigns a fundamental rating of 1 / 10 to BRR.


What is the valuation status for BRR stock?

ChartMill assigns a valuation rating of 0 / 10 to PROCAP FINANCIAL INC (BRR). This can be considered as Overvalued.


Can you provide the profitability details for PROCAP FINANCIAL INC?

PROCAP FINANCIAL INC (BRR) has a profitability rating of 0 / 10.


What is the financial health of PROCAP FINANCIAL INC (BRR) stock?

The financial health rating of PROCAP FINANCIAL INC (BRR) is 5 / 10.